MedDataX Logo

Neutrophil-to-Lymphocyte Ratio in Predicting Outcomes of Patients With Aneurysmal Subarachnoid Hemorrhage in a Tertiary Care Hospital in Nepal

NCT ID: NCT06683469

Last Updated: 2024-11-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-10

Study Completion Date

2023-07-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study uses Neutrophil-to-Lymphocyte Ratio to Predict Outcomes of Patients with Aneurysmal Subarachnoid Hemorrhage which will be beneficial in taking early decisions for surgery , patient counselling etc

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome

NCT02483351

Subarachnoid Hemorrhage
COMPLETED PHASE2/PHASE3

Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)

NCT01585311

Subarachnoid Hemorrhage (SAH) Tachycardia
TERMINATED

Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.

NCT02684812

Subarachnoid Hemorrhage
COMPLETED PHASE2/PHASE3

Predictive Accuracy of PLR and PNR in Detecting ETIC

NCT07046858

Trauma Injury Coagulopathy
RECRUITING

The Size of Pelvic Hematoma Can be a Predictive Factor for Angioembolization

NCT03519594

Multiple Pelvic Fractures
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SAH (Subarachnoid Hemorrhage)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients \> 18 years of age, of either genders, ethnicity and location who presented to the emergency department within 72 hours of the onset of symptoms who underwent surgical or interventional treatment for SAH caused by a ruptured intracranial aneurysm

Exclusion Criteria

* excluded patients with traumatic SAH, history of infection or stroke within eight weeks, underlying cancer, severe kidney or liver disease, history of auto-immune or hematologic disorder lost to follow-up within three months and individuals declining informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sujan Paudel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sujan Paudel

Dr

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tribhuvan University Teaching Hospital

Kathmandu, , Nepal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Nepal

References

Explore related publications, articles, or registry entries linked to this study.

Guo Y, Liu J, Zeng H, Cai L, Wang T, Wu X, Yu K, Zheng Y, Chen H, Peng Y, Yu X, Yan F, Cao S, Chen G. Neutrophil to lymphocyte ratio predicting poor outcome after aneurysmal subarachnoid hemorrhage: A retrospective study and updated meta-analysis. Front Immunol. 2022 Aug 9;13:962760. doi: 10.3389/fimmu.2022.962760. eCollection 2022.

Reference Type RESULT
PMID: 36016932 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MaharajgunjMed

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratio in Predicting the Incidence of Nausea and Vomiting
NCT05636163 UNKNOWN
Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery
NCT02097602 COMPLETED
Coagulopathy in Acute Aortic Syndrome
NCT05149261 UNKNOWN
Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation
NCT06696079 RECRUITING NA
Hemostasis Profile in Patients With Severe Subarachnoid Hemorrhage
NCT03745456 UNKNOWN
Management of Anticoagulants and Antithrombotics in Patients With CSDH
NCT05079295 UNKNOWN
Nursing Risk Management in Emergency SAH Surgery Using Healthcare Failure Mode and Effect Analysis(HFMEA)
NCT07315048 COMPLETED NA
Antibiotic-associated Coagulopathy
NCT02172833 UNKNOWN
Trauma Induced Coagulopathy and Inflammation
NCT03128658 COMPLETED
Coagulation Factors and Postpartum Hemorrhage
NCT02604602 COMPLETED
Major Bleeding Risk Associated With Antithrombotics
NCT02886533 COMPLETED
Intraoperative Angioembolization in the Management of Pelvic Fracture-Related Hemodynamic Instability
NCT00755365 COMPLETED
Global Hemostasis Monitoring by Using Sonoclot Signature in Traumatic Patients
NCT04100395 NOT_YET_RECRUITING
Factor XIII and Pulmonary Embolism in Neurosurgical Patients
NCT01106937 UNKNOWN
Study of the Role of Hemostasis in Perioperative Anaphylaxis
NCT04825158 UNKNOWN
A 48 Subject Study Using Non-invasive Multi-Technology Measurements for Early Detection of Ongoing Hemorrhage
NCT04814810 TERMINATED
External Validation of the Clinical Pre-hospital "Red- Flag" Alert for Activation of Intra-hospital Hemorrhage Control Response in Blunt Trauma.
NCT05820217 UNKNOWN
Effects of Different Concentrations of Pressurized-heparin Flushing Fluid on Coagulation and Platelet Function Monitored by the Sonoclot Analyzer
NCT04355273 COMPLETED NA
Shock, Whole Blood, and Assessment of TBI S.W.A.T. (LITES TO 2)
NCT03402035 COMPLETED
Thromboelastometry-identified Haemostatic Changes in Isolated Traumatic Brain Injury
NCT03616808 COMPLETED NA
Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery
NCT03353259 TERMINATED PHASE2/PHASE3
Factor XIII Activity in Gastrointestinal Bleedings
NCT05933135 COMPLETED
Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma
NCT07200674 RECRUITING
A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
NCT00198575 UNKNOWN
The Incidence of Early Trauma Induced Coagulopathy and Hyperfibrinolysis in Severely Injured Trauma Patients in the Emergency Room: a Retrospective Cohort Study
NCT07186712 COMPLETED